CAMKK2 and Familial prostate cancer: Some studies have reported CaMKK2 involvement in the pathophysiology of prostatic cancer, where CaMKK2 is identified as an androgen target gene and increased expression and activation of CaMKK2/AMPK signaling affects cell migration, invasion and anabolic pathways [33-35].